6-carboxyfluorescein has been researched along with Glioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neuhaus, W; Noe, CR; Poetsch, V | 1 |
1 other study(ies) available for 6-carboxyfluorescein and Glioma
| Article | Year |
|---|---|
Serum-derived immunoglobulins neutralize adverse effects of amyloid-beta peptide on the integrity of a blood-brain barrier in vitro model.
Topics: Amyloid beta-Peptides; Animals; Biological Transport; Blood-Brain Barrier; Cell Line, Tumor; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Interactions; Fluoresceins; Fluorometry; Glioma; Immunoglobulins, Intravenous; Lipopolysaccharides; Peptide Fragments; Rats; Time Factors; Tumor Necrosis Factor-alpha | 2010 |